Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$39.26 -0.03 (-0.08%)
At close: Sep 30, 2026 · 4:00 PM EDT

Harmony Biosciences Holdings (HRMY) Finished Goods (2023 - 2024)

Updated

Harmony Biosciences Holdings' Finished Goods came in at $2.77 million for Q4 2024, up 21.1% from $2.28 million a year earlier but down 17.0% from the prior quarter.

Analysis

Harmony Biosciences Holdings (HRMY) Finished Goods (2023 - 2024) Analysis & Trends

Going back to Q4 2023, Harmony Biosciences Holdings' Finished Goods data covers 5 quarters.

  • Going back by year, Finished Goods was $2.28 million in FY2023.
  • The five-year range for quarterly Finished Goods is $2.28 million (Q4 2023) to $3.33 million (Q3 2024).
  • Business Quant data shows HRMY's Finished Goods at $3.33 million (Q3 2024), $2.76 million (Q2 2024) and $3.1 million (Q1 2024) in the three quarters before Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Harmony Biosciences Holdings 2.28 Bn -474.81 Mn 198.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 2.77 Mn
Sep 30, 2024 3.33 Mn
Jun 30, 2024 2.76 Mn
Mar 31, 2024 3.10 Mn
Dec 31, 2023 2.28 Mn
API Access

Harmony Biosciences Holdings Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=HRMY&period=max&api_key=YOUR_API_KEY